As an inhibitor of the complement membrane attack complex, CD59 can inhibit the incorporation of multiple copies of C9 into the complex and protect the host cell from damage by complement in normal physiological conditions, and also suppress complement-dependent cytotoxicity and play a role in antitumor activity in breast cancer patients [23]. The gene discussed is C9; the disease is breast carcinoma.